Skip to content

Stanford radiology chief discusses sensing and diagnosing cancer before it becomes a disease

In this video, Stanford radiology chief Sam Gambhir, MD, PhD, discusses emerging early cancer detection technologies and imaging strategies. Gambhir explains how he and colleagues are developing new methods for detecting blood-borne substances, or other biomarkers, shed by tumors early enough to identify, locate and eliminate the cancerous growths while they’re still small. He also touches on how as these new early detection technologies are validated they hold the potential to yield benefits in the treatment of cancer and other diseases.

Previously: Nanoparticles home in on human tumors growing in mice’s brains, increase accuracy of surgical removal, Tumors can grow for decades before blood-based detection, study shows and Nanomedicine moves one step closer to reality

Popular posts

Category:
Biomedical research
How do the new COVID-19 vaccines work?

The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.